Neoadjuvant treatment of HER2-positive breast cancer – pathological complete response (pCR) as a surrogate of long term outcomes in the context of regulatory guidelines and reimbursement recommendations.
Journal title: JOURNAL OF HEALTH POLICY & OUTCOMES RESEARCH
Authors: Anna Panasiuk, Dariusz Pawlik, Małgorzata Budasz-Świderska, Marcin Kaczor
Subject(s):